Smart Money Is Betting Big In VKTX Options
Smart Money Is Betting Big In VKTX Options
Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
深口袋的投资者对Viking Therapeutics（NASDAQ:VKTX）采取了看淡的态度，这是市场参与者不应忽视的事情。我们在Benzinga的公共期权记录跟踪中发现了这个重要的动向。这些投资者的身份尚不清楚，但VKTX的这样巨大的变动通常意味着即将发生一些重要的事情。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
我们从今天的观察到的信息中获知维京治疗公司的9项非同寻常期权交易，这种活动水平超出寻常。
The general mood among these heavyweight investors is divided, with 0% leaning bullish and 77% bearish. Among these notable options, 4 are puts, totaling $180,170, and 5 are calls, amounting to $377,168.
这些重量级投资者的总体情绪分歧，0%看涨，77%看跌。在这些显著的期权中，有4个看跌，总额为180,170美元，有5个看涨，总额为377,168美元。
What's The Price Target?
目标价是多少？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $75.0 for Viking Therapeutics, spanning the last three months.
通过评估成交量和未平仓合约量，显然主要的市场推动者关注维京治疗公司的20.0到75.0美元的价格区间，涵盖了最近三个月。
Volume & Open Interest Development
成交量和持仓量的评估是期权交易中的一个关键步骤。这些指标揭示了阿里巴巴集团（Alibaba Gr Hldgs）特定执行价格期权的流动性和投资者兴趣。下面的数据可视化了在过去30天内，阿里巴巴集团（Alibaba Gr Hldgs）在执行价格在74.0美元到120.0美元区间内的看涨看跌期权中，成交量和持仓量的波动情况。
In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 486.33 with a total volume of 113.00.
就流动性和兴趣而言，维京治疗公司期权今日的平均未平仓合约量为486.33，总成交量为113.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Viking Therapeutics's big money trades within a strike price range of $20.0 to $75.0 over the last 30 days.
在下面的图表中，我们能够跟踪维京治疗公司大额交易中期权看涨和看跌未平仓合约和成交量在20.0到75.0美元行权价格区间内的发展，时间跨度为过去30天。
Viking Therapeutics Call and Put Volume: 30-Day Overview
维京治疗公司看涨和看跌期权的成交量：30天概述
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $37.0 | $33.3 | $34.73 | $20.00 | $173.6K | 299 | 24 |
| VKTX | CALL | TRADE | NEUTRAL | 01/16/26 | $33.8 | $29.1 | $31.48 | $25.00 | $94.4K | 54 | 30 |
| VKTX | PUT | TRADE | BEARISH | 09/20/24 | $9.1 | $8.6 | $8.91 | $50.00 | $62.3K | 954 | 2 |
| VKTX | PUT | SWEEP | BEARISH | 11/15/24 | $6.0 | $5.9 | $6.0 | $40.00 | $53.4K | 915 | 40 |
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $37.0 | $35.5 | $35.75 | $20.00 | $39.3K | 299 | 2 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看涨 | 交易 | 看淡 | 01/16/26 | $37.0 | $33.3 | 34.73美元 | $20.00 | 173.6K | 299 | 24 |
| VKTX | 看涨 | 交易 | 中立 | 01/16/26 | $33.8应该是指目标价$33.8。 | $29.1 | $31.48 | $25.00 | $94.4K | 54 | 30 |
| VKTX | 看跌 | 交易 | 看淡 | 09/20/24 | $9.1 | $8.6美元 | $8.91 | $50.00 | $62.3K | 954 | 2 |
| VKTX | 看跌 | SWEEP | 看淡 | 11/15/24 | $6.0 | $5.9 | $6.0 | $40.00 | $53.4K | 915 | 40 |
| VKTX | 看涨 | 交易 | 看淡 | 01/16/26 | $37.0 | $35.5 | 35.75美元 | $20.00 | $39.3K | 299 | 2 |
About Viking Therapeutics
关于Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家卫生服务提供商，专门从事代谢和内分泌障碍领域的生物制药开发。该公司的临床项目流水线包括VK2809、VK5211、VK0214产品。VK2809和VK0214是口服、组织和受体亚型选择性的甲状腺激素受体β激动剂。VK5211是一种口服、非类固醇选择性雄激素受体调节剂。
Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
经过检查Viking Therapeutics的期权交易模式，我们现在将我们的注意力直接转向公司。这一转变使我们可以深入研究其当前的市场地位和表现。
Viking Therapeutics's Current Market Status
维京治疗公司的当前市场状态
- With a trading volume of 1,554,339, the price of VKTX is down by -0.42%, reaching $49.63.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 6 days from now.
- 维京治疗公司的交易量为1,554,339，价格下跌-0.42%，达到49.63美元。
- 目前的RSI值表明该股票目前处于超买和超卖之间的中立状态。
- 下一个收益报告将在6天后发布。
Expert Opinions on Viking Therapeutics
维京治疗公司的专家意见
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $97.5.
在过去的一个月里，有2位行业分析师分享了他们关于该公司的见解，提出了97.5美元的平均目标价格。
- In a cautious move, an analyst from Morgan Stanley downgraded its rating to Overweight, setting a price target of $105.
- An analyst from HC Wainwright & Co. downgraded its action to Buy with a price target of $90.
- 为了谨慎起见，摩根士丹利的一名分析师将其评级降级为看涨，设定目标价为105美元。
- Wainwright公司的一名分析师将其行动降级为买入，并设定了90美元的目标价格。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性的交易调整、利用各种因子和保持市场动态来减轻这些风险。使用Benzinga Pro即可了解Viking Therapeutics的最新期权交易情况，并获取实时警报。